UBE1

UBE1

UBE1 Informations sur la molécule

Molecule Name
Ubiquitin-like modifier-activating enzyme 1
Alias de la molécule
A1S9T and BN75 temperature sensitivity complementing,A1S9T,A1ST,AMCX1,GXP1,MGC4781,POC20 centriolar protein homolog,POC20,Protein A1S9,SMAX2,UBA1,UBA1, ubiquitin-activating enzyme E1 homolog A,UBA1A,UBE1,UBE1A1S9,UBE1X,ubiquitin-activating enzyme E1 (A1S9
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 1 Clinical
Alias de la cible
EC:6.2.1.45,UBE1,Ubiquitin-Activating Enzyme E1 (A1S9T And BN75 Temperature Sensitivity Complementing),UBA1, Ubiquitin-Activating Enzyme E1 Homolog (Yeast),POC20 Centriolar Protein Homolog (Chlamydomonas),Ubiquitin-Like Modifier Activating Enzyme 1,Testicular Secretory Protein Li 63,EC 6.2.1.45,CFAP124,AMCX1,POC20,SMAX2,UBA1A,UBE1X,A1S9,A1ST,GXP1,Ubiquitin-activating enzyme E1,Protein A1S9,A1S9T,Ubiquitin-like modifier-activating enzyme 1,UBA1,Ubiquitin Like Modifier Activating Enzyme 1,A1S9T And BN75 Temperature Sensitivity Complementing,UBA1, Ubiquitin-Activating Enzyme E1 Homolog A,POC20 Centriolar Protein Homolog
Contexte de la molécule
The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]

UBE1 Liste de produits

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • InsectCells(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
UBE1
Human UBE1 / UBA1 Protein, His Tag (MALS verified)
Human
InsectCells
MALSSDS-PAGE

$115.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
TAK-243TAK-243; MLN-7243Phase 1 ClinicalTakeda Pharmaceutical Co Ltd
Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Solid tumours
Details
Customer Reviews